Fundraising Update

Current Status

Updated:  December 31, 2024

Since the Donation page went live on December 16, 2024, CLL Topics has received a total of $310,828.34 from 555 donors.

Most of the funds raised by CLL Topics are dedicated to clinical research in CLL. We have funded or committed to fund three clinical trials and more are in evaluation or under discussion. The first project we have chosen to fund was a clinical trial of the green tea extract, EGCG, as a therapeutic agent in CLL, conducted by the Mayo Clinic, Rochester, MN, followed by a trial involving low-dose Rituxan at the University of Virginia and one involving the use of immune modulators in improving the efficacy of influenza vaccination at the Royal Bournemouth Hospital in the UK. We are in discussions with investigators at various other institutions regarding their research opportunities and have selected additional investigations that may receive grant support from CLL Topics. Your donations will enable us to offer critical support for these projects.

You can see a complete list of projects funded todate at Sponsored Projects and a statement of our project selection and sponsorship philosophy in an article titled Sponsorship Philosophy.

We have reached our fundraising goals for the year and as of June 30, 2024 we will temporarily suspend fundraising while our publisher, webmaster and chief administrator (same guy – works for free) is undergoing treatment for his CLL. Suspending this labor-intensive activity will lighten up our operational commitments and allow us to concentrate our time and effort on maintaining our publishing and educational activities, including this website and Topics Alerts. We will report on the results from our sponsored projects as and when they become available. For an update, please see Topics Alert #269

Thank you for your encouragement and generous support.

— The Topics Team